{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:26:28Z","timestamp":1779207988068,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AQ-0039"],"award-info":[{"award-number":["AQ-0039"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048417"],"award-info":[{"award-number":["R01DA048417"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.neuropharm.2023.109777","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:28:19Z","timestamp":1699428499000},"page":"109777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-5397","authenticated-orcid":false,"given":"David R.","family":"Maguire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109777_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0022-3565(25)23036-1","article-title":"Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine","volume":"255","author":"Adams","year":"1990","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.tips.2018.08.001","article-title":"Immunopharmacotherapies for treating opioid use disorder","volume":"39","author":"Banks","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109777_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-3565(25)20829-1","article-title":"Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis","volume":"251","author":"Bertalmio","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130000567","article-title":"Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands","volume":"153","author":"Bergman","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3565(24)39155-4","article-title":"Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine","volume":"294","author":"Broadbear","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00213-004-1891-x","article-title":"Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary\u2013adrenal axis in rhesus monkeys","volume":"176","author":"Broadbear","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109787","article-title":"Effects of \u0394\u2079-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC\/CBD mixtures on fentanyl versus food choice in rhesus monkeys","volume":"244","author":"Carey","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109777_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/cpt.2098","article-title":"Countermeasures for preventing and treating opioid overdose","volume":"109","author":"France","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2023.109777_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/jpet.122.001267","article-title":"Attenuation of the positive-reinforcing effects of ultra-potent fentanyl analogs, along with those of fentanyl and heroin, during daily treatment with methocinnamox in rhesus monkeys","volume":"384","author":"Gerak","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.118.253286","article-title":"Reversal and prevention of the respiratory-depressant effects of heroin by the novel \u03bc-opioid receptor antagonist methocinnamox in rhesus monkeys","volume":"368","author":"Gerak","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-023-06451-2","article-title":"Alkoxy chain length governs the potency of 2-benzylbenzimidazole \u2018nitazene\u2019 opioids associated with human overdose","author":"Glatfelter","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00176-X","article-title":"Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor","volume":"395","author":"Houshyar","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109777_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","article-title":"Responding to the opioid crisis in North America and beyond: recommendations of the Stanford\u2013Lancet Commission","volume":"399","author":"Humphreys","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109777_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1124\/jpet.120.000387","article-title":"Methocinnamox reverses and prevents fentanyl-induced ventilatory depression in rats","volume":"377","author":"Jimenez","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1124\/jpet.301.2.698","article-title":"Relative reinforcing effects of three opioids with different durations of action","volume":"301","author":"Ko","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib18","series-title":"Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System","author":"Madras","year":"2020"},{"key":"10.1016\/j.neuropharm.2023.109777_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.122.001318","article-title":"Effects of 2,5-dimethoxy-4-methylamphetamine (DOM) and 2-piperazin-1-yl-quinoline (quipazine) on fentanyl versus food choice in rhesus monkeys","volume":"384","author":"Maguire","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.122.001233","article-title":"Effects of daily methocinnamox treatment on fentanyl self-administration in rhesus monkeys","volume":"382","author":"Maguire","year":"2022","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jeab.831","article-title":"Behavioral pharmacology of methocinnamox: a potential new treatment for opioid overdose and opioid use disorder","volume":"119","author":"Maguire","year":"2023","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2023.109777_bib22","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/s41386-020-0698-8","article-title":"Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys","volume":"45","author":"Maguire","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/jpet.118.252353","article-title":"Long-lasting effects of methocinnamox on opioid self-administration in rhesus monkeys","volume":"368","author":"Maguire","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib24","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-020-05592-y","article-title":"Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys","volume":"237","author":"Minervini","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1037\/a0013088","article-title":"Mu\/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability","volume":"16","author":"Negus","year":"2008","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2023.109777_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1213\/00000539-199102000-00015","article-title":"Cardiovascular, respiratory, and analgesic effects of fentanyl in unanesthetized rhesus monkeys","volume":"72","author":"Nussmeier","year":"1991","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2023.109777_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2005.07.060","article-title":"Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox","volume":"1058","author":"Peckham","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109777_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib29","series-title":"Drug Overdose Deaths in the United States, 2001\u20132021. NCHS Data Brief, No 457","author":"Spencer","year":"2022"},{"key":"10.1016\/j.neuropharm.2023.109777_bib30","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/s41386-020-0717-9","article-title":"The lasting impact of methocinnamox on opioid self-administration","volume":"45","author":"Townsend","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108348","article-title":"A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys","volume":"218","author":"Townsend","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2023.109777_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1176\/appi.ajp.20230273","article-title":"Fentanyl and other opioid use disorders: treatment and research needs","volume":"180","author":"Volkow","year":"2023","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109777_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130050534","article-title":"In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay","volume":"136","author":"Walker","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109777_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.887","article-title":"Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox","volume":"9","author":"Zamora","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuropharm.2023.109777_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-5347(25)00270-8","article-title":"Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands","volume":"241","author":"Zimmerman","year":"1987","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109777_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s002130050185","article-title":"Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception","volume":"129","author":"Zernig","year":"1997","journal-title":"Psychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823003672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:56:52Z","timestamp":1762214212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823003672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S0028390823003672"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109777","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109777"}}